EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Challenges Posed by the Banff Classification: Diagnosis and Treatment of Chronic Active T-Cell-Mediated Rejection

Izumi Yamamoto, Mayuko Kawabe, Ayaka Hayashi, Akimitsu Kobayashi, Hiroyasu Yamamoto, Takashi Yokoo

Nephron · 2023

DOI: 10.1159/000530158 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nephron, 2023. Verfasst von Izumi Yamamoto und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Kidney Transplantation, Kidney Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The three primary sites of acute T-cell-mediated rejection (TCMR) in transplanted kidneys are the tubular epithelial cells, interstitium, and the vascular endothelial cells. The pathology of acute lesions is characterized by inflammatory cell infiltration; the final diagnosis suggested by the Banff 2019 classification is guided by grading of tubulitis (the t score), interstitial inflammation (the i score), and endarteritis (the v score). Consistent major issues when using the Banff classification are the etiological classifications of interstitial fibrosis and tubular atrophy (IFTA). From 2015 to 2019, technological advances (i.e., genetic analysis in paraffin sections) increased our understanding of IFTA status in patients with smoldering acute TCMR and the roles played by inflammatory cell infiltration (the i-IFTA score) and tubulitis (the t-IFTA score) in IFTA. These two scores were introduced when establishing the diagnostic criteria for chronic active TCMR. Despite the increase in complexity and the lack of a consensus treatment for chronic active TCMR, the Banff classification may evolve as new techniques (i.e., genetic analysis in paraffin sections and deep learning of renal pathology) are introduced. The Banff conference proceeded as follows. First, lesions were defined. Next, working groups were established to better understand the lesions and to derive better classification methods. Finally, the new Banff classification was developed. This approach will continue to evolve; the Banff classification will become a very useful diagnostic standard. This paper overviews the history of TCMR diagnosis using the Banff classification, and the clinical importance, treatment, and prospects for acute and chronic active TCMR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationKidney DiseasesHumansT-LymphocytesEndothelial CellsParaffinKidneyGraft RejectionBiopsy

Stichwörter der Autor:innen

Banff classificationKidney transplantationT-cell-mediated rejection

Substanzen

Paraffin

Autor:innen und Institutionen

  • Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.

Zitieren

APA

Yamamoto, I., Kawabe, M., Hayashi, A., Kobayashi, A., Yamamoto, H., & Yokoo, T. (2023). Challenges Posed by the Banff Classification: Diagnosis and Treatment of Chronic Active T-Cell-Mediated Rejection. Nephron. https://doi.org/10.1159/000530158

Vancouver

Yamamoto I, Kawabe M, Hayashi A, Kobayashi A, Yamamoto H, Yokoo T. Challenges Posed by the Banff Classification: Diagnosis and Treatment of Chronic Active T-Cell-Mediated Rejection. Nephron. 2023. doi:10.1159/000530158

BibTeX
@article{Yamamoto2023,
  author = {Yamamoto, Izumi and Kawabe, Mayuko and Hayashi, Ayaka and Kobayashi, Akimitsu and Yamamoto, Hiroyasu and Yokoo, Takashi},
  title = {Challenges Posed by the Banff Classification: Diagnosis and Treatment of Chronic Active T-Cell-Mediated Rejection},
  journal = {Nephron},
  year = {2023},
  doi = {10.1159/000530158}
}
Kostenlos starten →